FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, in particular, to a composition and method for inhibiting the onset of infection of Staphylococcus aureus using such composition. This composition contains a therapeutically effective amount of an analog of the leukocidin polypeptide A of S. aureus.
EFFECT: present invention makes it possible to increase the effectiveness of the treatment of Staphylococcus aureus infection due to the preparation of the disclosed vaccine composition.
10 cl, 21 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS AND THEIR USE | 2018 |
|
RU2795545C2 |
| STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION | 2011 |
|
RU2644237C2 |
| METHODS OF TREATMENT AND PREVENTION OF STAFILOCOCCA INFECTIONS OF GOLDEN AND RELATED DISTURBANCES | 2012 |
|
RU2635462C2 |
| METHOD OF INHIBITING LEUCOCIDIN ED TOXICITY OF STAPHYLOCOCCUS AUREUS IN INDIVIDUAL | 2012 |
|
RU2609650C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS | 2015 |
|
RU2636780C1 |
| ANTIBODIES AGAINST TEICHOIC ACID CONJUGATE AND THEIR CONJUGATES | 2014 |
|
RU2687044C2 |
| ANTIBODIES AGAINST STAPHYLOCOCCUS AUREUS LEUKOTOXINS | 2019 |
|
RU2805969C2 |
| ANTIBODIES FOR SPECIFIC BINDING OF STAPHYLOCOCCUS AUREUS ALPHA-TOXIN AND METHODS OF APPLICATION | 2012 |
|
RU2620065C2 |
| COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS | 2014 |
|
RU2717306C2 |
| IMMUNOGENIC COMPOSITIONS OF STAPHYLOCOCCUS AUREUS ANTIGENS | 2010 |
|
RU2536981C9 |
